Solid Biosciences Inc.Most RecentCompany & Industry OverviewsSolid Biosciences and Its Focus on Duchenne Muscular DystrophyIn the fourth quarter of 2017, Solid Biosciences initiated a Phase 1/2 clinical trial called IGNITE DMD to test SGT-001 in the United States.
Company & Industry OverviewsSolid Biosciences and Its Focus on Duchenne Muscular DystrophyIn the fourth quarter of 2017, Solid Biosciences initiated a Phase 1/2 clinical trial called IGNITE DMD to test SGT-001 in the United States.
